ALTUNÖREN, O. Et Al. 2020. Can vasohibin-1, an endothelium-derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?. SEMINARS IN DIALYSIS , vol.33, no.5 , 418-427.

ALTUNÖREN, O., Kerkutluoglu, M., Sarisik, F. N., Akkus, G., SEYİTHANOĞLU, M., Doganer, A., ... Sezal, D. T.(2020). Can vasohibin-1, an endothelium-derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?. SEMINARS IN DIALYSIS , vol.33, no.5, 418-427.

ALTUNÖREN, ORÇUN Et Al. "Can vasohibin-1, an endothelium-derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?," SEMINARS IN DIALYSIS , vol.33, no.5, 418-427, 2020

ALTUNÖREN, ORÇUN Et Al. "Can vasohibin-1, an endothelium-derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?." SEMINARS IN DIALYSIS , vol.33, no.5, pp.418-427, 2020

ALTUNÖREN, O. Et Al. (2020) . "Can vasohibin-1, an endothelium-derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?." SEMINARS IN DIALYSIS , vol.33, no.5, pp.418-427.

@article{article, author={ORÇUN ALTUNÖREN Et Al. }, title={Can vasohibin-1, an endothelium-derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?}, journal={SEMINARS IN DIALYSIS}, year=2020, pages={418-427} }